See the latest news and media coverage for CardioSignal. We track all announcements, press releases, and industry mentions in real time, all in one place.
Smartphone-based medical device for atrial fibrillation detection and heart monitoring
cardiosignal.comLast updated
In short: CardioSignal raised $10 million Series A and earned EU MDR Class IIb certification for its heart-detection apps.
Smartphone-based atrial fibrillation detection is selected as the winning digital screening solution. CardioSignal and DKV collaborate to integrate it into DKV's health ecosystem for insured customers.
Updates feature sensor checks, refined vitals display, improved accessibility, quiet measurements, and revised documents. It launches CardioSignal Inside SDK for B2B partners.
CardioSignal achieved EU MDR Class IIb certification and will offer a new SDK partnership model for integrating atrial fibrillation detection into partner apps.
LocalTapiola offers 5,000 customers free access to CardioSignal's app to detect atrial fibrillation and help prevent strokes starting June 2025.
CardioSignal today announced the closing of $10 million in Series A funding, led by DigiTx Partners, with participation from Sandwater and existing investor Maki.vc. David...
Finnish health technology company CardioSignal has successfully secured $10 million in Series A funding, supporting its mission to advance...
5000 over 50-year-olds are offered a free app for trial that identifies a common heart rhythm disorder. Heart problems. In the illustration image, Meilahti's joint emergency services. IMAGE: Henri Kärkkäinen 8.6.202518:02 Rony Hopeakangas 5000 for 50-75-year-olds are offered...
CardioSignal scores $10M for heart disease detection technology · Tech-enabled heart disease detection company CardioSignal announced it secured...
Track CardioSignal and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CardioSignal and other trending companies.
